Literature DB >> 26858260

The phenotype of migraine with unilateral cranial autonomic symptoms documents increased peripheral and central trigeminal sensitization. A case series of 757 patients.

P Barbanti1, C Aurilia2, V Dall'Armi3, G Egeo2, L Fofi2, S Bonassi3.   

Abstract

BACKGROUND: Migraine with unilateral cranial autonomic symptoms (UAS) is a putative migraine endophenotype with convincing response to trigeminal-targeted treatments that still needs a thorough characterization.
OBJECTIVE: The objective of this article is to carefully investigate the clinical phenotype of migraine with UAS in a large group of patients for more accurate migraine diagnoses, improved clinical management, and better outcome prediction.
METHODS: We studied 757 consecutive episodic and chronic migraineurs in a tertiary headache clinic with face-to-face interviews, detailing in depth their lifestyle, sociodemographic and headache characteristics.
RESULTS: Migraineurs with UAS (37.4%) differed from the general migraine population with respect to longer attack duration (OR = 2.47, p < 0.02, having >72-hour long attacks), more strictly unilateral (OR = 3.18, p < 0.001) and severe headache (OR = 1.72, p = 0.011), more frequent allodynia (OR = 3.03, p < 0.001) and photophobia (OR = 1.87, p = 0.019).
CONCLUSIONS: Migraine patients with UAS are characterized not only by symptoms due to intense peripheral trigeminal activation but also to central sensitization. Our study broadens the knowledge on the clinical and phenotypic characteristics of migraine with UAS, suggests pathophysiological implications, and supports the need for future prospective clinical studies. © International Headache Society 2016.

Entities:  

Keywords:  Migraine; cranial autonomic symptoms; disability; pathophysiology; trigemino-autonomic reflex

Mesh:

Year:  2016        PMID: 26858260     DOI: 10.1177/0333102416630579

Source DB:  PubMed          Journal:  Cephalalgia        ISSN: 0333-1024            Impact factor:   6.292


  16 in total

1.  Autonomic Symptoms and Allodynia in Migraine.

Authors:  Esme Ekizoğlu
Journal:  Noro Psikiyatr Ars       Date:  2018-09-03       Impact factor: 1.339

2.  Current understanding of trigeminal ganglion structure and function in headache.

Authors:  Karl Messlinger; Andrew F Russo
Journal:  Cephalalgia       Date:  2018-07-10       Impact factor: 6.292

Review 3.  Headache and Autonomic Dysfunction: a Review.

Authors:  Courtney Iser; Karissa Arca
Journal:  Curr Neurol Neurosci Rep       Date:  2022-08-22       Impact factor: 6.030

4.  Migraine: Are migraine endophenotypes needed?

Authors:  Jes Olesen
Journal:  Nat Rev Neurol       Date:  2016-03-29       Impact factor: 42.937

Review 5.  Onabotulinum toxin A in the treatment of chronic migraine: patient selection and special considerations.

Authors:  Piero Barbanti; Patrizia Ferroni
Journal:  J Pain Res       Date:  2017-09-29       Impact factor: 3.133

Review 6.  PACAP and migraine headache: immunomodulation of neural circuits in autonomic ganglia and brain parenchyma.

Authors:  James A Waschek; Serapio M Baca; Simon Akerman
Journal:  J Headache Pain       Date:  2018-03-13       Impact factor: 7.277

7.  Synergistic but separable sensory changes in postural tachycardia syndrome and chronic migraine.

Authors:  Melissa M Cortez; Leah Millsap; K C Brennan
Journal:  Clin Auton Res       Date:  2020-11-10       Impact factor: 4.435

8.  Non-invasive Vagus Nerve Stimulation (nVNS) as mini-prophylaxis for menstrual/menstrually related migraine: an open-label study.

Authors:  Licia Grazzi; Gabriella Egeo; Anne H Calhoun; Candace K McClure; Eric Liebler; Piero Barbanti
Journal:  J Headache Pain       Date:  2016-10-03       Impact factor: 7.277

9.  Feasibility of serum CGRP measurement as a biomarker of chronic migraine: a critical reappraisal.

Authors:  Mi Ji Lee; Sook-Yeon Lee; Soohyun Cho; Eun-Suk Kang; Chin-Sang Chung
Journal:  J Headache Pain       Date:  2018-07-13       Impact factor: 7.277

Review 10.  Cross-talk signaling in the trigeminal ganglion: role of neuropeptides and other mediators.

Authors:  Karl Messlinger; Louis K Balcziak; Andrew F Russo
Journal:  J Neural Transm (Vienna)       Date:  2020-02-22       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.